Search results for "Hazard"

showing 10 items of 1517 documents

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial

2019

###EgeUn###

AdultMalemedicine.medical_specialtyHerpes Zoster Vaccinemedicine.medical_treatmentvirusesVaccines Synthetic/administration & dosageHematopoietic stem cell transplantationPlaceboInjections IntramuscularTransplantation Autologous01 natural sciencesHerpes Zoster Vaccine/administration & dosage03 medical and health sciences0302 clinical medicineAutologous stem-cell transplantationAdjuvants ImmunologicInternal medicinehemic and lymphatic diseasesmedicineHumansSingle-Blind Method030212 general & internal medicine0101 mathematicsAdverse effectHospitalization/statistics & numerical dataProportional Hazards ModelsImmunocompromised hostintegumentary systembusiness.industryIncidence (epidemiology)010102 general mathematicsvirus diseasesGeneral MedicineMiddle AgedNeuralgia Postherpetic/prevention & controlTransplantationsurgical procedures operativeHerpes Zoster/epidemiologyhematopoietic stem cell transplantationoncologyincidenceFemaleZoster vaccinebusinessFollow-Up Studiesmedicine.drug
researchProduct

The relationship between the dietary inflammatory index (DII®) and incident depressive symptoms: A longitudinal cohort study

2018

Abstract Background Diet is a common source of inflammation, and inflammation is associated with depression. We examined the association between the dietary inflammatory index (DII®), a validated measure of inflammatory potential of the diet, and risk of depression in a cohort of older North American adults. Methods This longitudinal study, with a follow-up of 8 years, included 3648 participants (1577 males, 2071 females; mean age: 60.6 years) with/at risk of knee osteoarthritis. DII® scores were calculated using the validated Block Brief 2000 Food-Frequency Questionnaire. Center for Epidemiological Studies Depression-20 scale was used to define depressive symptoms. The relationship between…

AdultMalemedicine.medical_specialtyLongitudinal studyNeuroimmunologyOld ageDiet SurveysCohort Studies03 medical and health sciences0302 clinical medicineInternal medicineEpidemiologyHumansMedicineLongitudinal Studies030212 general & internal medicineHealth behaviorDepression (differential diagnoses)AgedProportional Hazards ModelsInflammationPsychiatric Status Rating ScalesDepressionbusiness.industryIncidenceIncidence (epidemiology)Hazard ratioConfoundingDepression Health behavior Neuroimmunology Old ageMiddle AgedDietPsychiatry and Mental healthClinical PsychologyQuartileCohortFemalebusiness030217 neurology & neurosurgeryDepression; Health behavior; Neuroimmunology; Old age; Adult; Aged; Cohort Studies; Depression; Diet; Diet Surveys; Female; Follow-Up Studies; Humans; Incidence; Inflammation; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; Psychiatric Status Rating ScalesFollow-Up StudiesJournal of Affective Disorders
researchProduct

A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-dise…

2011

Background This trial was designed to prove superiority of irinotecan over etoposide combined with carboplatin in extensive-disease small-cell lung cancer. Patients and methods Patients were randomly assigned to receive carboplatin area under the curve 5 mg x min/ml either in combination with irinotecan 50 mg/m2 on days 1, 8, and 15 (IP) or etoposide 140 mg/m2 on days 1-3 (EP). Primary end point was progression-free survival (PFS) at 6 months. Secondary end points were overall survival (OS), response rate, and toxicity. Results Of 226 patients, 216 were eligible. Median PFS was 6.0 months [95% confidence interval (CI) 5.0-7.0] in the IP arm and 6.0 months (95% CI 5.2-6.8) in EP arm (P = 0.0…

AdultMalemedicine.medical_specialtyLung NeoplasmsMedizinIrinotecanGastroenterologyDisease-Free SurvivalCarboplatinchemistry.chemical_compoundInternal medicineGermanyAntineoplastic Combined Chemotherapy ProtocolsClinical endpointMedicineHumansLung cancerEtoposideAgedEtoposideAged 80 and overbusiness.industryHazard ratioArea under the curveHematologyMiddle Agedmedicine.diseaseSmall Cell Lung CarcinomaCarboplatinConfidence intervalSurgeryIrinotecanOncologychemistryCamptothecinFemalebusinessmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Oncologic Long-term Outcome of Elective Nephron-sparing Surgery Versus Radical Nephrectomy in Patients With Renal Cell Carcinoma Stage pT1b or Greate…

2011

Objectives To analyze the oncologic outcome and overall survival (OS) for patients with renal cell carcinoma (RCC) >4 cm undergoing radical nephrectomy (RN) or elective nephron-sparing surgery (NSS) in a matched-pair cohort. Methods From 1988 to 2007, we identified 829 patients in our clinic treated with either RN (n = 641) or open NSS (n = 188) for renal masses >4 cm. After matching the cohort for age, time of surgery, grade, TNM stage, tumor size, and sex and excluding patients with metastases, benign lesions with an imperative indication, and those with missing records, 173 remained for oncologic analysis. OS, cancer-specific survival, and progression-free survival were estimated using t…

AdultMalemedicine.medical_specialtyMatched-Pair AnalysisUrologymedicine.medical_treatmentNephrectomyRenal cell carcinomaHumansMedicineIn patientStage (cooking)Carcinoma Renal CellAgedProportional Hazards ModelsAged 80 and overbusiness.industryProportional hazards modelHazard ratioMiddle Agedmedicine.diseaseKidney NeoplasmsConfidence intervalNephrectomySurgeryTreatment OutcomeElective Surgical ProceduresCohortDisease ProgressionFemalebusinessUrology
researchProduct

The role of lifestyle behaviour on the risk of hypertension in the SUN cohort: The hypertension preventive score

2019

Lifestyles may influence the risk of hypertension. Our objective was to assess the association between a healthy-lifestyle score and the incidence of hypertension. The SUN Project is a dynamic, prospective cohort of Spanish university graduates (1999-2014). Among 14,057 participants initially free of hypertension, we assessed the influence of lifestyle-related factors based on a 10-item score that we previously reported to be associated with lower risk of major cardiovascular events. However, we focused on factors related to hypertension risk according to previous scientific evidence and international clinical guidelines and constructed a 6-item score including: no smoking, moderate-to-high…

AdultMalemedicine.medical_specialtyMediterranean dietEpidemiologyHealth BehaviorBinge drinkingDiet MediterraneanLower risk01 natural sciencesBody Mass IndexCohort Studies03 medical and health sciencesSex Factors0302 clinical medicineSurveys and QuestionnairesInternal medicinePrevalenceHumansMedicineHealthy LifestyleProspective Studies030212 general & internal medicine0101 mathematicsProspective cohort studyExerciseProportional Hazards Modelsbusiness.industryProportional hazards modelIncidence (epidemiology)Smoking010102 general mathematicsAge FactorsRolePublic Health Environmental and Occupational HealthMiddle AgedCardiovascular DiseasesSpainHypertensionMultivariate AnalysisCohortLinear ModelsFemalebusinessRisk Reduction BehaviorBody mass indexPreventive Medicine
researchProduct

Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment.

2009

Background: There are a few and conflicting results from randomised controlled trials (RCTs) pertaining to the influence of gender in response to currently used disease modifying drugs in Multiple Sclerosis (MS). Observational studies may be especially valuable for answering effectiveness questions in subgroups not studied in RCTs. Objective: To conduct a post-marketing analysis aimed to evaluate the gender effect on Interferon beta (IFN beta) treatment response in a cohort of relapsing (RR) MS patients. Methods: A cohort of 2570 IFN beta-treated RRMS was prospectively followed for Lip to 7 years in 15 Italian MS Centers. Cox proportional hazards regression models were used to assess gender…

AdultMalemedicine.medical_specialtyMultiple SclerosisPropensity scoreDiseasegender; interferon beta; multiple sclerosis; observational study; propensity scoreLower riskSeverity of Illness IndexMultiple sclerosis Interferon beta Gender Observational study Propensity scoreCohort StudiesDisability EvaluationYoung AdultSex Factorsgender multiple sclerosis treatment interferonDouble-Blind MethodInternal medicineObservational studymedicinegenderConfidence IntervalsOdds RatioProduct Surveillance PostmarketingHumansImmunologic FactorsMultiple sclerosiProportional Hazards ModelsExpanded Disability Status ScaleProportional hazards modelbusiness.industryMultiple sclerosisDrug Administration RoutesInterferon-betamedicine.diseaseInterferon betaSurgeryNeurologyItalyCohortPropensity score matchingRegression AnalysisSettore MED/26 - NeurologiaObservational studyFemaleNeurology (clinical)business
researchProduct

Cigarette Smoking Status at Diagnosis and Recurrence in Intermediate-risk Nonemuscle-invasive Bladder Carcinoma

2013

Objective To study the effect of smoking status at diagnosis on recurrence in intermediate-risk non–muscle-invasive bladder carcinoma treated by transurethral resection (TUR) of the bladder and early intravesical chemotherapy. Methods Tumor characteristics and smoking status were recorded in 395 patients entered in a randomized multicenter trial comparing 2 different schedules of early intravesical chemotherapy. All patients received intravesical epirubicin (80 mg/50 mL) within 6 hours after TUR, followed by 5 more weekly instillations with (arm B) or without (arm A) monthly instillations for 1 year. Smoking habit was investigated at diagnosis through a structured questionnaire. Multivariat…

AdultMalemedicine.medical_specialtyMultivariate analysisTime Factorsintravesical chemotherapy non-muscle invasive bladder cancerUrologymedicine.medical_treatmentcigarette smokingKaplan-Meier EstimateCystectomyGastroenterologyDisease-Free SurvivalSettore MED/24 - UrologiaCystectomyCigarette smokingRisk FactorsMulticenter trialInternal medicinemedicineCarcinomaHumansAgedEpirubicinProportional Hazards ModelsAged 80 and overAntibiotics AntineoplasticProportional hazards modelbusiness.industryCarcinomaSmokingMiddle AgedFormer Smokermedicine.diseaseintermediate-risk tumorrecurrence.Combined Modality TherapySurgeryUrinary Bladder NeoplasmsMultivariate AnalysisFemaleNeoplasm Recurrence LocalbusinessEpirubicinmedicine.drug
researchProduct

Mature Survival Data for 176 Patients Younger Than 60 Years With Primary Myelofibrosis Diagnosed Between 1976 and 2005: Evidence for Survival Gains i…

2009

In the past 20 years, management of primary myelofibrosis (PMF) has incorporated new treatment approaches, but survival benefits have not been confirmed in controlled studies. This retrospective study includes 176 consecutive patients younger than age 60 years in whom PMF was diagnosed during a 30-year period (1976-2005). Median age at diagnosis was 50 years (range, 18-59 years), and 98 patients (55%) were men. At the time of this report, 99 patients (56%) had died; the 77 surviving patients were followed up for a median of 8 years (range, 4-24 years). Overall median survival was 9.2 years, and 15- and 20-year survival rates were 32% and 20%, respectively. According to the Dupriez Prognosti…

AdultMalemedicine.medical_specialtyMultivariate analysisTransplantation ConditioningAdolescentmedicine.medical_treatmentDiseaseHematopoietic stem cell transplantationKaplan-Meier EstimateDisease-Free SurvivalSettore MED/15 - Malattie Del Sanguemyelofibrosis survivalSurvival dataInternal medicinemedicineHumansMyelofibrosisSurvival rateProportional Hazards ModelsRetrospective Studiesbusiness.industryProportional hazards modelBrief ReportHematopoietic Stem Cell TransplantationRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapyUnited StatesSurgerySurvival RatePrimary MyelofibrosisMultivariate AnalysisFemalebusiness
researchProduct

Declining exposures to lead and cadmium contribute to explaining the reduction of cardiovascular mortality in the US population, 1988-2004.

2017

Background Lead and cadmium exposures have markedly declined in the USA following the implementation of large-scale public health policies and could have contributed to the unexplained decline in cardiovascular mortality in US adults. We evaluated the potential contribution of lead and cadmium exposure reductions to explain decreasing cardiovascular mortality trends occurring in the USA from 1988-94 to 1999-2004. Methods Prospective study in 15 421 adults ≥40 years old who had participated in the National Health and Nutrition Examination Survey 1988-94 or 1999-2004. We estimated the amount of change in cardiovascular mortality over time that can be independently attributed to the intermedia…

AdultMalemedicine.medical_specialtyNational Health and Nutrition Examination SurveyEpidemiologyPopulationchemistry.chemical_elementUrine030204 cardiovascular system & hematologyRate ratioHazardous SubstancesToxicology03 medical and health sciences0302 clinical medicineAge DistributionEnvironmental healthMedicineHumans030212 general & internal medicineProspective StudiesSex DistributionProspective cohort studyeducationAgedCadmiumeducation.field_of_studybusiness.industryPublic healthGeneral MedicineEnvironmental ExposureMiddle AgedNutrition SurveysConfidence intervalUnited StateschemistryLeadCardiovascular DiseasesLinear ModelsFemalebusinessCadmiumInternational journal of epidemiology
researchProduct

Factors Related to the Occurrence of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension

2002

The objective of the study was to assess the factors related to the occurrence of microalbuminuria during the follow-up of a young adult group with essential hypertension that had not been previously treated. Normo-albuminuric essential hypertensives, <50 years old, who had not been previously treated with antihypertensive drugs and who did not have diabetes mellitus were included. After the initial evaluation, patients were treated using only nonpharmacological measures (n=62), β-blockers (n=38), ACE inhibitors (n=64), calcium channel blockers (n=8), and several classes (n=15). Measurements were taken for office blood pressure, biochemical profile, and 24-hour urinary albumin excretion…

AdultMalemedicine.medical_specialtyNifedipineAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsEssential hypertensionEnalaprilLisinoprilRisk FactorsInternal medicineInternal MedicinemedicineAlbuminuriaBisoprololHumansYoung adultAntihypertensive AgentsProportional Hazards ModelsProteinuriabusiness.industryFollow up studiesMiddle AgedCalcium Channel Blockersmedicine.diseaseTreatment OutcomeEndocrinologyBlood pressureAtenololHypertensionAlbuminuriaRegression AnalysisFemaleMicroalbuminuriamedicine.symptombusinessPreviously treatedHypertension
researchProduct